222 related articles for article (PubMed ID: 2644821)
1. A critical look at the clinical use of antacids in acid-peptic disease and gastric acid rebound.
Texter EC
Am J Gastroenterol; 1989 Feb; 84(2):97-108. PubMed ID: 2644821
[TBL] [Abstract][Full Text] [Related]
2. The gastric acid conundrum in peptic ulcer.
Dobrilla G; Steele A; Comberlato M; Amplatz S
Ital J Gastroenterol; 1990 Jun; 22(3):142-6. PubMed ID: 2131944
[TBL] [Abstract][Full Text] [Related]
3. Acid rebound: fact or fiction.
Holtermüller KH
Hepatogastroenterology; 1982 Aug; 29(4):135-7. PubMed ID: 7129334
[No Abstract] [Full Text] [Related]
4. New aspects of clinical pharmacology of antacids.
Konturek SJ
J Physiol Pharmacol; 1993 Sep; 44(3 Suppl 1):5-21. PubMed ID: 8260735
[TBL] [Abstract][Full Text] [Related]
5. Current concepts in clinical therapeutics: peptic ulcer disease.
Siepler JK; Mahakian K; Trudeau WT
Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
[TBL] [Abstract][Full Text] [Related]
6. Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases.
Andersson K; Carlsson E
Pharmacol Ther; 2005 Dec; 108(3):294-307. PubMed ID: 16000224
[TBL] [Abstract][Full Text] [Related]
7. Antacids and hormones.
Holtermüller KH; Dehdaschti M
Scand J Gastroenterol Suppl; 1982; 75():24-31. PubMed ID: 6755653
[TBL] [Abstract][Full Text] [Related]
8. Medical treatment of peptic ulcers.
Deveney CW; Deveney KE
Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
[TBL] [Abstract][Full Text] [Related]
9. Antacids in the treatment of peptic ulcer disease.
Garrigues-Gil V
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():73-7. PubMed ID: 2657291
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
Huang JQ; Hunt RH
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
[TBL] [Abstract][Full Text] [Related]
11. Antacids. Indications and limitations.
Ching CK; Lam SK
Drugs; 1994 Feb; 47(2):305-17. PubMed ID: 7512903
[TBL] [Abstract][Full Text] [Related]
12. [Value of antacids in ulcer therapy. Continuing the tradition or scientific progress?].
Szelenyi I
Leber Magen Darm; 1987 Jul; 17(3):150-62. PubMed ID: 3613813
[TBL] [Abstract][Full Text] [Related]
13. Drug therapy for peptic ulcer: drugs that act on the gastric mucosa.
Kauffman GL
J Clin Gastroenterol; 1981; 3(Suppl 2):95-101. PubMed ID: 6119340
[TBL] [Abstract][Full Text] [Related]
14. [Lattice structure antacids and antacid mixtures].
Miederer SE; Schmidt C
Z Gastroenterol; 1987 Aug; 25 Suppl 3():130-5. PubMed ID: 3660893
[TBL] [Abstract][Full Text] [Related]
15. Effect of pirenzepine and antacids on postprandial intragastric pH.
Weberg R; Narverud G; Berstad A
Hepatogastroenterology; 1983 Oct; 30(5):202-4. PubMed ID: 6688998
[TBL] [Abstract][Full Text] [Related]
16. Acid reduction in peptic ulcer disease. Choosing therapy according to drug interactions, individual response, and cost.
Parent K
Postgrad Med; 1994 Nov; 96(6):53-9. PubMed ID: 7971612
[TBL] [Abstract][Full Text] [Related]
17. Antacids and anticholinergics in the treatment of duodenal ulcer.
Walan A
Clin Gastroenterol; 1984 May; 13(2):473-99. PubMed ID: 6086186
[TBL] [Abstract][Full Text] [Related]
18. The limitations of current therapy in peptic ulcer disease.
Salena BJ; Hunt RH
Clin Invest Med; 1987 May; 10(3):171-7. PubMed ID: 3304747
[TBL] [Abstract][Full Text] [Related]
19. Clinical use of antacids.
Halter F
J Physiol Pharmacol; 1993 Sep; 44(3 Suppl 1):61-74. PubMed ID: 8260736
[TBL] [Abstract][Full Text] [Related]
20. Management of dyspepsia and peptic ulcer disease.
Ryan SW
Altern Ther Health Med; 2005; 11(5):26-9; quiz 30. PubMed ID: 16189945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
